Park Ha Biological Technology CO., LTD. (BYAH) — SEC Filings

Overview

Park Ha Biological Technology CO., LTD. (BYAH) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a F-3 filed on Apr 16, 2026: Park Ha Biological Technology Co., Ltd. filed an F-3 registration statement on April 16, 2026, for an unspecified amount of securities. The filing includes legal opinions from Ogier and consents from WWC, P.C. and Jiangsu Junjin Law Firm. The company is located at NO. 50 XIUXI ROAD, WUXI CITY, F4.

Sentiment Summary

Across 13 filings, the sentiment breakdown is: 1 bearish, 12 neutral. The dominant filing sentiment for Park Ha Biological Technology CO., LTD. is neutral.

Filing Type Overview

Park Ha Biological Technology CO., LTD. (BYAH) has filed 1 F-3, 11 6-K, 1 20-F with the SEC between Dec 2024 to Apr 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (13)

• Park Ha Biological Tech Files F-3 Registration — F-3 · Apr 16, 2026 Risk: medium
  Park Ha Biological Technology Co., Ltd. filed an F-3 registration statement on April 16, 2026, for an unspecified amount of securities. The filing includes lega
• 6-K Filing — 6-K · Dec 30, 2025
• Park Ha Biological Tech Files 6-K, Announces EGM — 6-K · Nov 28, 2025 Risk: low
  Park Ha Biological Technology Co., Ltd. filed a Form 6-K on November 28, 2025, reporting on its activities for November 2025. The filing indicates the company i
• Park Ha Biological Technology Changes Ticker to BYAH — 6-K · Oct 24, 2025 Risk: low
  On October 24, 2025, Park Ha Biological Technology Co., Ltd. announced a change in its trading symbol on the Nasdaq stock exchange from "PHH" to "BYAH". This ch
• Park Ha Biological Technology Holds 2025 Annual Meeting — 6-K · Oct 8, 2025 Risk: low
  Park Ha Biological Technology Co., Ltd. held its 2025 Annual General Meeting on October 3, 2025, in Wuxi, Jiangsu Province, China. The meeting addressed matters
• Park Ha Biological Tech Files 6-K for Sept 2025 — 6-K · Sep 18, 2025 Risk: low
  Park Ha Biological Technology Co., Ltd. filed a Form 6-K on September 18, 2025, reporting for the month of September 2025. The company, incorporated in F4 and h
• Park Ha Biological Technology Receives Nasdaq Non-Compliance Letter — 6-K · Sep 5, 2025 Risk: medium
  Park Ha Biological Technology Co., Ltd. received a non-compliance letter from Nasdaq on September 2, 2025, regarding the minimum bid price requirement. The comp
• Park Ha Biological Tech Files 6-K for April 2025 Period — 6-K · Aug 26, 2025 Risk: low
  Park Ha Biological Technology Co., Ltd. filed a Form 6-K on August 26, 2025, reporting on its operating and financial review and prospects for the period ending
• Park Ha Biological Director Resigns — 6-K · Aug 25, 2025 Risk: low
  Park Ha Biological Technology Co., Ltd. announced on August 25, 2025, that Mr. Da Yang has resigned as an independent director, effective immediately. The resig
• Park Ha Biological Technology Files 2024 Annual Report — 20-F · Feb 24, 2025 Risk: medium
  Park Ha Biological Technology Co., Ltd. filed its annual report on Form 20-F for the fiscal year ended October 31, 2024. The company, incorporated in F4 and hea
• Park Ha Biological Tech Signs Underwriting Deal — 6-K · Jan 24, 2025 Risk: medium
  On December 26, 2024, Park Ha Biological Technology Co., Ltd. entered into an underwriting agreement with Dawson James Securities, Inc. This agreement pertains
• Park Ha Biological Technology Appoints New Independent Director — 6-K · Jan 7, 2025 Risk: low
  Park Ha Biological Technology Co., Ltd. announced on January 7, 2025, the appointment of Da Yang as an independent director. The company is based in Wuxi, Jiang
• Park Ha Biological Enters Underwriting Agreement for Share Offering — 6-K · Dec 30, 2024 Risk: medium
  On December 26, 2024, Park Ha Biological Technology Co., Ltd. entered into an underwriting agreement with Dawson James Securities, Inc. This agreement pertains

Related Companies

PHH

Frequently Asked Questions